Literature DB >> 33139263

The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults.

Alvin Lee Day1, Kevin L Winthrop2, Jeffrey R Curtis3.   

Abstract

Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33139263     DOI： 10.3949/ccjm.87a.20056

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  12 in total

1.  Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios.

Authors:  Ernesto Cairoli; Gerard Espinosa
Journal:  Med Clin (Engl Ed)       Date:  2021-08-07

2.  Narrative Review: Addressing Covid-19 Vaccine Concerns in Special and Vulnerable Populations.

Authors:  Kent A Owusu; Muhammad K Effendi; Melissa L Thompson Bastin; Samad Tirmizi; Ishaq Lat; Mahmoud A Ammar
Journal:  Hosp Pharm       Date:  2022-01-19

3.  Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Authors:  Kazuki Fujioka; Akiko Kasahara; Takashi Kida; Wataru Fujii; Takahiro Seno; Makoto Wada; Masataka Kohno; Yutaka Kawahito
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-11       Impact factor: 3.373

4.  B cell therapy and the use of RNA-based COVID-19 vaccines.

Authors:  Anastasia Vishnevetsky; Chris Hawkes; Jeannette Lechner-Scott; Gavin Giovannoni; Michael Levy; Daniela Pohl
Journal:  Mult Scler Relat Disord       Date:  2021-03-08       Impact factor: 4.339

5.  Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2.

Authors:  Parakkal Deepak; Wooseob Kim; Michael A Paley; Monica Yang; Alexander B Carvidi; Alia A El-Qunni; Alem Haile; Katherine Huang; Baylee Kinnett; Mariel J Liebeskind; Zhuoming Liu; Lily E McMorrow; Diana Paez; Dana C Perantie; Rebecca E Schriefer; Shannon E Sides; Mahima Thapa; Maté Gergely; Suha Abushamma; Michael Klebert; Lynne Mitchell; Darren Nix; Jonathan Graf; Kimberly E Taylor; Salim Chahin; Matthew A Ciorba; Patricia Katz; Mehrdad Matloubian; Jane A O'Halloran; Rachel M Presti; Gregory F Wu; Sean P J Whelan; William J Buchser; Lianne S Gensler; Mary C Nakamura; Ali H Ellebedy; Alfred H J Kim
Journal:  medRxiv       Date:  2021-04-09

6.  The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?

Authors:  N Winchester; C Calabrese; L H Calabrese
Journal:  Pathog Immun       Date:  2021-03-08

7.  Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.

Authors:  Anna Carolina Faria Moreira Gomes Tavares; Ana Karla Guedes de Melo; Vítor Alves Cruz; Viviane Angelina de Souza; Joana Starling de Carvalho; Ketty Lysie Libardi Lira Machado; Lilian David de Azevedo Valadares; Edgard Torres Dos Reis Neto; Rodrigo Poubel Vieira de Rezende; Maria Fernanda Brandão de Resende Guimarães; Gilda Aparecida Ferreira; Alessandra de Sousa Braz; Rejane Maria Rodrigues de Abreu Vieira; Marcelo de Medeiros Pinheiro; Sandra Lúcia Euzébio Ribeiro; Blanca Elena Gomes Rios Bica; Kátia Lino Baptista; Izaias Pereira da Costa; Claudia Diniz Lopes Marques; Maria Lúcia Lemos Lopes; José Eduardo Martinez; Rina Dalva Neubarth Giorgi; Lícia Maria Henrique da Mota; Marcos Antônio Araújo da Rocha Loures; Eduardo Dos Santos Paiva; Odirlei André Monticielo; Ricardo Machado Xavier; Adriana Maria Kakehasi; Gecilmara Cristina Salviato Pileggi
Journal:  Adv Rheumatol       Date:  2022-01-17

Review 8.  Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.

Authors:  Zeinab Mohseni Afshar; Arefeh Babazadeh; Alireza Janbakhsh; Feizollah Mansouri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2021-10-22       Impact factor: 11.043

9.  Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients.

Authors:  Hamza Mahmood Bajwa; Frederik Novak; Anna Christine Nilsson; Christian Nielsen; Dorte K Holm; Kamilla Østergaard; Agnes Hauschultz Witt; Keld-Erik Byg; Isik S Johansen; Kristen Mittl; William Rowles; Scott S Zamvil; Riley Bove; Joseph J Sabatino; Tobias Sejbaek
Journal:  Mult Scler Relat Disord       Date:  2022-03-06       Impact factor: 4.808

10.  Agricultural Pesticides and Shingles Risk in a Prospective Cohort of Licensed Pesticide Applicators.

Authors:  Christine G Parks; Jonathan N Hofmann; Laura E Beane Freeman; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2021-07-28       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.